oxonic acid has been researched along with Cirrhosis in 6 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study was designed to explore the effects of Withaferin A (WFA) on hyperuricemia-induced kidney injury and its action mechanism." | 8.02 | Withaferin A protects against hyperuricemia induced kidney injury and its possible mechanisms. ( Bai, Y; Li, P; Ru, J; Tang, L; Wang, J; Zhao, X, 2021) |
| " The effects of API on renal function, inflammation, fibrosis, and uric acid (UA) metabolism in mice with HN were evaluated." | 8.02 | Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway. ( Cao, Y; Chen, Y; Huang, Q; Jiang, Y; Li, L; Li, Y; Luo, J; Pang, J; Wu, T; Zhang, L; Zhao, Z; Zhou, P, 2021) |
| "Uric acid has promoted renal fibrosis and inflammation in experimental studies, but some studies have shown nephroprotective effects due to alleviated oxidative stress." | 4.31 | Moderate hyperuricaemia ameliorated kidney damage in a low-renin model of experimental renal insufficiency. ( Eräranta, A; Honkanen, T; Kurra, V; Lakkisto, P; Mustonen, J; Myllymäki, J; Paavonen, T; Pörsti, I; Riutta, A; Tikkanen, I, 2023) |
| "The study was designed to explore the effects of Withaferin A (WFA) on hyperuricemia-induced kidney injury and its action mechanism." | 4.02 | Withaferin A protects against hyperuricemia induced kidney injury and its possible mechanisms. ( Bai, Y; Li, P; Ru, J; Tang, L; Wang, J; Zhao, X, 2021) |
| " The effects of API on renal function, inflammation, fibrosis, and uric acid (UA) metabolism in mice with HN were evaluated." | 4.02 | Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway. ( Cao, Y; Chen, Y; Huang, Q; Jiang, Y; Li, L; Li, Y; Luo, J; Pang, J; Wu, T; Zhang, L; Zhao, Z; Zhou, P, 2021) |
| "Hyperuricemia is an independent risk factor for chronic kidney disease (CKD)." | 1.56 | Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy. ( Feng, Y; Fu, P; Guo, F; Huang, R; Liao, D; Ma, L; Shi, M; Zeng, X, 2020) |
| " The effects of casein or soya protein combined with palm or safflower-seed oil on various serum parameters and renal histology were investigated on hyperuricaemic rats." | 1.36 | Relative efficacy of casein or soya protein combined with palm or safflower-seed oil on hyperuricaemia in rats. ( Chiou, HY; Lai, SH; Lo, HC; Wang, YH; Yang, Y, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kurra, V | 1 |
| Eräranta, A | 1 |
| Paavonen, T | 1 |
| Honkanen, T | 1 |
| Myllymäki, J | 1 |
| Riutta, A | 1 |
| Tikkanen, I | 1 |
| Lakkisto, P | 1 |
| Mustonen, J | 1 |
| Pörsti, I | 1 |
| Shi, M | 1 |
| Guo, F | 1 |
| Liao, D | 1 |
| Huang, R | 1 |
| Feng, Y | 1 |
| Zeng, X | 1 |
| Ma, L | 1 |
| Fu, P | 1 |
| Zhao, X | 1 |
| Wang, J | 1 |
| Tang, L | 1 |
| Li, P | 1 |
| Ru, J | 1 |
| Bai, Y | 1 |
| Li, Y | 1 |
| Zhao, Z | 1 |
| Luo, J | 1 |
| Jiang, Y | 1 |
| Li, L | 1 |
| Chen, Y | 1 |
| Zhang, L | 1 |
| Huang, Q | 1 |
| Cao, Y | 1 |
| Zhou, P | 1 |
| Wu, T | 1 |
| Pang, J | 1 |
| Li, H | 2 |
| Liu, X | 1 |
| Lee, MH | 1 |
| Lo, HC | 1 |
| Wang, YH | 1 |
| Chiou, HY | 1 |
| Lai, SH | 1 |
| Yang, Y | 1 |
6 other studies available for oxonic acid and Cirrhosis
| Article | Year |
|---|---|
Moderate hyperuricaemia ameliorated kidney damage in a low-renin model of experimental renal insufficiency.
Topics: Animals; Fibrosis; Hyperuricemia; Inflammation; Kidney; Kidney Diseases; Nephrectomy; Oxonic Acid; R | 2023 |
Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy.
Topics: Adenine; Animals; Biphenyl Compounds; Cytokines; Fatty Acid-Binding Proteins; Fibrosis; Hepatitis A | 2020 |
Withaferin A protects against hyperuricemia induced kidney injury and its possible mechanisms.
Topics: Animals; Apoptosis; Disease Models, Animal; Fibrosis; Hyperuricemia; Kidney; Kidney Diseases; Male; | 2021 |
Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.
Topics: Animals; Apigenin; beta Catenin; Creatinine; Dose-Response Relationship, Drug; Fibrosis; Glucose Tra | 2021 |
Vitamin C alleviates hyperuricemia nephropathy by reducing inflammation and fibrosis.
Topics: Animals; Antioxidants; Ascorbic Acid; Fibrosis; Hyperuricemia; Inflammation; Kidney Diseases; Male; | 2021 |
Relative efficacy of casein or soya protein combined with palm or safflower-seed oil on hyperuricaemia in rats.
Topics: Albumins; Analysis of Variance; Animals; Blood Urea Nitrogen; Caseins; Cholesterol; Creatinine; Diet | 2010 |